![](https://investorshub.advfn.com/uicon/83357.png?cb=1596264753)
Thursday, April 22, 2021 10:07:30 AM
Are they even conducting any FDA Trials on their Psych portfolio or is it all Euro based?
All the while Revive has multiple ongoing Trials/IND's for Covid, CBD's, Psych Delivery Methods and Psych's themselves.
Revive is slowly, with little fanfare, building it's Psychedelic portfolio by investing/engaging in collaborative research into Delivery Systems for Treatments and securing it's own Production and Supply of Psilocybin.
?When? this Sector becomes mainstreamed for treating persons with psychological issues the company will be well positioned to take a leading role because of these actions, especially re the delivery of Psych doses....have seen only one other company doing official research in this area.
As for our current position, the only ones complaining are those who have become impatient, which I fully understand, and those who are desperate for Revive's stock to go parabolic so they can flip.
Which group do you fall under!?!
WELCOME TO UNICORNLAND
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM